343 related articles for article (PubMed ID: 11163505)
21. Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT).
Corvò R; Lamparelli T; Bruno B; Barra S; Van Lint MT; Vitale V; Bacigalupo A
Bone Marrow Transplant; 2002 Dec; 30(11):717-23. PubMed ID: 12439693
[TBL] [Abstract][Full Text] [Related]
22. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
Katsanis E; Shapiro RS; Robison LL; Haake RJ; Kim T; Pescovitz OH; Ramsay NK
Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
Ho VT; Weller E; Lee SJ; Alyea EP; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2001; 7(4):223-9. PubMed ID: 11349809
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary function and complications subsequent to autologous bone marrow transplantation.
Carlson K; Bäcklund L; Smedmyr B; Oberg G; Simonsson B
Bone Marrow Transplant; 1994 Nov; 14(5):805-11. PubMed ID: 7889014
[TBL] [Abstract][Full Text] [Related]
25. Renal toxicity in children undergoing total body irradiation for bone marrow transplant.
Esiashvili N; Chiang KY; Hasselle MD; Bryant C; Riffenburgh RH; Paulino AC
Radiother Oncol; 2009 Feb; 90(2):242-6. PubMed ID: 18973960
[TBL] [Abstract][Full Text] [Related]
26. Toxicities of total-body irradiation for pediatric bone marrow transplantation.
Chou RH; Wong GB; Kramer JH; Wara DW; Matthay KK; Crittenden MR; Swift PS; Cowan MJ; Wara WM
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):843-51. PubMed ID: 8598361
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation.
Beyzadeoglu M; Dirican B; Oysul K; Arpaci F; Pak Y
Haematologia (Budap); 2002; 32(1):25-30. PubMed ID: 12243552
[TBL] [Abstract][Full Text] [Related]
28. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
[TBL] [Abstract][Full Text] [Related]
29. Cataract in children after bone marrow transplantation: relation to conditioning regimen.
Holmström G; Borgström B; Calissendorff B
Acta Ophthalmol Scand; 2002 Apr; 80(2):211-5. PubMed ID: 11952491
[TBL] [Abstract][Full Text] [Related]
30. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
31. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
32. Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de Moelle.
Resbeut M; Cowen D; Blaise D; Gluckman E; Cosset JM; Rio B; Pene F; Milpied N; Cuillère JC; Reiffers J
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):509-17. PubMed ID: 7852113
[TBL] [Abstract][Full Text] [Related]
33. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.
Boulad F; Bromley M; Black P; Heller G; Sarafoglou K; Gillio A; Papadopoulos E; Sklar C
Bone Marrow Transplant; 1995 Jan; 15(1):71-6. PubMed ID: 7742758
[TBL] [Abstract][Full Text] [Related]
34. Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens.
Shinde A; Yang D; Frankel P; Liu A; Han C; Del Vecchio B; Schultheiss T; Cheng J; Li R; Kim D; Radany EH; Hui S; Somlo G; Rosenthal J; Stein A; Forman S; Wong JYC
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1025-1033. PubMed ID: 31421151
[TBL] [Abstract][Full Text] [Related]
35. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G; Socié G; Gebhard F; Bernaudin F; Thuret I; Vannier JP; Demeocq F; Leverger G; Pico JL; Rubie H; Mechinaud F; Reiffers J; Gratecos N; Troussard X; Jouet JP; Simonin G; Gluckman E; Maraninchi D
J Clin Oncol; 1997 Jun; 15(6):2238-46. PubMed ID: 9196136
[TBL] [Abstract][Full Text] [Related]
36. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.
Mikell JL; Waller EK; Switchenko JM; Rangaraju S; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khoury HJ; Khan MK
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):360-9. PubMed ID: 24837891
[TBL] [Abstract][Full Text] [Related]
37. Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia.
van Kempen-Harteveld ML; Belkacémi Y; Kal HB; Labopin M; Frassoni F
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1367-74. PubMed ID: 11955751
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
Sakellari I; Gavriilaki E; Chatziioannou K; Papathanasiou M; Mallouri D; Batsis I; Bousiou Z; Bouziana S; Constantinou V; Douka V; Apostolou C; Iskas M; Lalayanni C; Athanasiadou A; Sotiropoulos D; Yannaki E; Gianouzakos V; Anagnostopoulos A
Ann Hematol; 2018 Oct; 97(10):1987-1994. PubMed ID: 29869673
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
40. Cataracts after autologous bone marrow transplantation in children.
Frisk P; Hagberg H; Mandahl A; Söderberg P; Lönnerholm G
Acta Paediatr; 2000 Jul; 89(7):814-9. PubMed ID: 10943964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
